UBS Group’s Korro Bio KRRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $232K | Sell |
18,581
-55,630
| -75% | -$695K | ﹤0.01% | 5390 |
|
|
2025
Q1 | $1.29M | Buy |
74,211
+1,172
| +2% | +$20.4K | ﹤0.01% | 3996 |
|
|
2024
Q4 | $2.78M | Buy |
73,039
+63,309
| +651% | +$2.41M | ﹤0.01% | 3451 |
|
|
2024
Q3 | $325K | Buy |
9,730
+5,317
| +120% | +$178K | ﹤0.01% | 4364 |
|
|
2024
Q2 | $149K | Buy |
4,413
+4,142
| +1,528% | +$140K | ﹤0.01% | 4747 |
|
|
2024
Q1 | $24.4K | Sell |
271
-366
| -57% | -$32.9K | ﹤0.01% | 5661 |
|
|
2023
Q4 | $30.5K | Buy |
637
+600
| +1,622% | +$28.8K | ﹤0.01% | 5631 |
|
|
2023
Q3 | $693 | Sell |
37
-49
| -57% | -$918 | ﹤0.01% | 7183 |
|
|
2023
Q2 | $1.49K | Sell |
86
-25
| -23% | -$432 | ﹤0.01% | 6825 |
|
|
2023
Q1 | $2.79K | Sell |
111
-42
| -27% | -$1.06K | ﹤0.01% | 7342 |
|
|
2022
Q4 | $29.4K | Buy |
153
+27
| +21% | +$5.2K | ﹤0.01% | 6086 |
|
|
2022
Q3 | $11K | Sell |
126
-5
| -4% | -$437 | ﹤0.01% | 7201 |
|
|
2022
Q2 | $10K | Hold |
131
| – | – | ﹤0.01% | 6930 |
|
|
2022
Q1 | $14K | Sell |
131
-150
| -53% | -$16K | ﹤0.01% | 6901 |
|
|
2021
Q4 | $72K | Buy |
281
+263
| +1,461% | +$67.4K | ﹤0.01% | 5506 |
|
|
2021
Q3 | $7K | Sell |
18
-18
| -50% | -$7K | ﹤0.01% | 7166 |
|
|
2021
Q2 | $18K | Sell |
36
-585
| -94% | -$293K | ﹤0.01% | 6356 |
|
|
2021
Q1 | $296K | Buy |
621
+586
| +1,674% | +$279K | ﹤0.01% | 4251 |
|
|
2020
Q4 | $62K | Buy |
35
+19
| +119% | +$33.7K | ﹤0.01% | 5009 |
|
|
2020
Q3 | $15K | Sell |
16
-178
| -92% | -$167K | ﹤0.01% | 5648 |
|
|
2020
Q2 | $226K | Buy |
194
+111
| +134% | +$129K | ﹤0.01% | 3931 |
|
|
2020
Q1 | $74K | Sell |
83
-78
| -48% | -$69.5K | ﹤0.01% | 4657 |
|
|
2019
Q4 | $141K | Buy |
+161
| New | +$141K | ﹤0.01% | 4803 |
|